Benzinga's Top #PreMarket Losers

shares dipped 76.16 percent to $1.70 in pre-market trading after the company reported Monday that its LIPO-202 top-line Phase 3 trial did not meet co-primary composite and secondary endpoints.

shares dipped 18.26 percent to $20.90 after the company lowered its forecast for fiscal 2016.

shares declined 4.77 percent to $150.18 after the company lowered its FY 2015 earnings guidance.

fell 3.13 percent to $57.60 in pre-market trading after the company priced 10.3 million share offering at $57.65 per share.

shares tumbled 2.65 percent to $25.73 in pre-market trading. VeriFone reported better-than-expected earnings for its fiscal fourth quarter, but the company issued a weak forecast for first quarter and fiscal 2016.